
Fueled in part by the opioid epidemic, the number of reported hepatitis C virus infections tripled in the United States between 2010 and 2015. As new infections continue to mount, new therapies have produced seismic changes in how HCV is treated clinically, leaving a gap between the most current clinical guidance and the ongoing demands of patient care.The New Hepatitis C is a current and essential review of HCV's epidemiology, diagnosis, and clinical approaches -- a clinician's guidebook for navigating everything from screening to treatment. Acute and chronic HCV are addressed, as are important new treatment options for HCV, management of side effects, and a convenient summary of clinical trials on the treatment of chronic hepatitis C.Updated to detail the standards of care that will define the next decade of HCV management, this evidence-based volume is an essential clinical reference for to any practitioner in gastroenterology, hepatology, infectious disease, transplant, or internal medicine.
This volume investigates the clinical management of Hepatitis C in the context of modern all-oral therapeutic advancements and rising infection rates. Nancy Reau, a specialist in hepatology, synthesizes current epidemiological data and clinical guidelines to bridge the gap between emerging medical research and daily patient care. The text provides a structured framework for practitioners to navigate the complexities of screening, diagnosis, and treatment protocols for both acute and chronic infections.
What You Will Find
Scope Limits
Medical professionals identify this text as a practical reference for clinicians working in gastroenterology and infectious disease departments. Experts highlight the utility of the book's evidence-based approach to navigating the rapidly evolving standards of care for Hepatitis C patients.
Page Count:
199
Publication Date:
2018-01-01
Publisher:
Oxford University Press
ISBN-10:
0190874791
ISBN-13:
9780190874797
No comments yet. Be the first to share your thoughts!